ABVC BIOPHARMA INC (ABVC)

US00091F3047 - Common Stock

0.5157  -0.01 (-2.7%)

Premarket: 0.529 +0.01 (+2.58%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
509.80K152.43K970.00K360.00K480.00K
Minority Interest Expense
474.61K394.63K-110.00K-800.00K800.00K
Cost Of Goods
139.98K302.04K290.00K10.00K20.00K
Gross Profit
369.82K-149.61K680.00K350.00K460.00K
Operating Expenses
6.70M8.07M15.79M12.05M8.97M
Research and Development
219.49K1.06M2.69M1.00M550.00K
Selling, General, and Administrative Expenses
6.48M7.00M13.10M11.05M8.42M
Operating Income
-6.33M-8.22M-15.11M-11.71M-8.51M
Interest Income/Expense
-2.42M-2.51M-370.00K-30.00K-1.55M
Other Income/Expense
98.58K69.28K80.00K520.00K200.00K
Non Recurring Items
N/A0.00-110.00K0.00-960.00K
Income Before Taxes
-8.65M-10.65M-15.51M-11.21M-10.81M
Income Tax
64.78K256.01K800.00K830.00K-220.00K
Net Income
-8.24M-10.52M-16.42M-12.84M-9.79M
EBITDA
-6.30M-8.19M-15.09M-11.70M-8.47M
 
Per Share Data
EPS Diluted Total Ops
-0.97-2.43-5.19-5.12-4.97
 
Statistics
Gross Profit Margin
72.54%-98.15%70.10%97.22%95.83%
Profit Margin
-1616.93%-6898.68%-1692.78%-3566.67%-2039.58%
Operating Profit Margin
-1242.19%-5390.35%-1557.73%-3252.78%-1772.92%

All data in USD

Charts